Operating Lease, Right-of-Use Asset of Iterum Therapeutics plc from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Iterum Therapeutics plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Iterum Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Iterum Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$264,000 -100% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $0 -$378,000 -100% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $19,000 -$445,000 -96% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $65,000 -$484,000 -88% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $264,000 -$366,000 -58% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $378,000 -$1,218,000 -76% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $464,000 -$1,220,000 -72% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $549,000 -$1,221,000 -69% 31 Dec 2023 10-K 07 Feb 2025 2024 FY
Q3 2023 $630,000 -$1,226,000 -66% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,596,000 -$618,000 -28% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $1,684,000 -$1,976,000 -54% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $1,770,000 -$1,971,000 -53% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $1,856,000 -$2,038,000 -52% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $2,214,000 -$1,870,000 -46% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $3,660,000 -$1,592,000 -30% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $3,741,000 -$1,520,000 -29% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $3,894,000 -$2,844,000 -42% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $4,084,000 -$2,809,000 -41% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $5,252,000 -$1,767,000 -25% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $5,261,000 -$1,883,000 -26% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $6,738,000 -$529,000 -7.3% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $6,893,000 -$494,000 -6.7% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $7,019,000 -$485,000 -6.5% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $7,144,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $7,267,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $7,387,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $7,504,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.